Showing results (61-70 of 196) with videos related to
Sort By:
Pageof 20
Journal of Molecular Medicine (Berlin, Germany)|June 16, 2007
IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cellsRosario Amato, Miranda Menniti, Valter Agosti, et al.Human Reproduction (Oxford, England)|June 25, 2010
Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-upStefano Palomba, Angela Falbo, Serena Del Negro, et al.Oncotarget|January 2, 2018
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myelomaMaria Angelica Stamato, Giada Juli, Enrica Romeo, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 29, 2025
Polyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?Michele Trimboli, Laura Marino, Ida Cataldina Iusi, et al.Cancer Biology & Therapy|February 27, 2009
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukinePierpaolo Correale, Salvatora Tindara Miano, Cinzia Remondo, et al.Molecular Therapy. Nucleic Acids|June 13, 2024
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigationAsad Ali, Katia Grillone, Serena Ascrizzi, et al.European Journal of Medicinal Chemistry|September 25, 2019
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquineRaffaella Catalano, Roberta Rocca, Giada Juli, et al.Critical Reviews in Oncology/Hematology|April 14, 2018
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysisDomenico Ciliberto, Nicoletta Staropoli, Francesca Caglioti, et al.Journal of Pharmaceutical and Biomedical Analysis|July 14, 2020
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MSSamantha Franzoni, Lisa Morbioli, Antonio Turtoro, et al.Cancer Biology & Therapy|April 1, 2009
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivoPierfrancesco Tassone, Maria Teresa Di Martino, Monica Ventura, et al.Pageof 20